<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38398746</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14020237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coagulation decompensation is one of the complications most frequently encountered in COVID-19 patients with a poor prognosis or long-COVID syndrome, possibly due to the persistence of SARS-CoV-2 infection in the cardiovascular system. To date, the mechanism underlying the alteration of the coagulation cascade in COVID-19 patients remains misunderstood and the anticoagulant protein S (PROS1) has been described as a potential risk factor for complications related to COVID-19, due to PLpro SARS-CoV-2 enzyme proteolysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Biopsies and blood samples were collected from SARS-CoV-2 positive and negative swab test subjects with coagulopathies (peripheral arterial thrombosis), and SARS-CoV-2 presence, ACE2 and CD147 expression, and plasmatic levels of PROS1 were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We reported a significant decrease of plasmatic PROS1 in the coagulopathic SARS-CoV-2 swab positive cohort, in association with SARS-CoV-2 in situ infection and CD147 peculiar expression. These data suggested that SARS-CoV-2 associated thrombotic/ischemic events might involve PROS1 cleavage by viral PLpro directly in the site of infection, leading to the loss of its anticoagulant function.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on this evidence, the identification of predisposing factors, such as CD147 increased expression, and the use of PLpro inhibitors to preserve PROS1 function, might be useful for COVID-19 coagulopathies management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2659-6362</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences and Biotechnology (SVEB), University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltrami</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5923-9265</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiuma</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4652-5550</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraresi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6742-7832</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences and Biotechnology (SVEB), University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passaro</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8462-7000</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Juana Maria Sanz</ForeName><Initials>JMS</Initials><Identifier Source="ORCID">0000-0003-3372-2758</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9507-9126</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Luca</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bortolotti</LastName><ForeName>Daria</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4496-9561</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FAR 2022</GrantID><Agency>University of Ferrara</Agency><Country/></Grant><Grant><GrantID>FIRD 2023</GrantID><Agency>University of Ferrara</Agency><Country/></Grant><Grant><GrantID>CROWDFUNDING</GrantID><Agency>University of Ferrara</Agency><Country/></Grant><Grant><GrantID>5X1000</GrantID><Agency>University of Ferrara</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PLpro</Keyword><Keyword MajorTopicYN="N">PROS1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coagulopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38398746</ArticleId><ArticleId IdType="pmc">PMC10890393</ArticleId><ArticleId IdType="doi">10.3390/life14020237</ArticleId><ArticleId IdType="pii">life14020237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu J., Li Y., Liu Q., Yao Q., Wang X., Zhang H., Chen R., Ren L., Min J., Deng F., et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell Discov. 2021;7:17. doi: 10.1038/s41421-021-00249-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00249-2</ArticleId><ArticleId IdType="pmc">PMC7987126</ArticleId><ArticleId IdType="pubmed">33758165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Pohlmann S. Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1. Cell Res. 2022;32:1&#x2013;2. doi: 10.1038/s41422-021-00603-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00603-9</ArticleId><ArticleId IdType="pmc">PMC8666617</ArticleId><ArticleId IdType="pubmed">34903854</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M., Zhang J., Ma X., Tan J., Chen L., Liu S., Xin Y., Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed. Pharmacother. 2020;131:110678. doi: 10.1016/j.biopha.2020.110678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110678</ArticleId><ArticleId IdType="pmc">PMC7444942</ArticleId><ArticleId IdType="pubmed">32861070</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J.Q., Du P., Wei D., Zhang Y., Sun X.X., Gong L., et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target Ther. 2020;5:283. doi: 10.1038/s41392-020-00426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M.B., Park E.Y., Lee T.S., Lee J. Effect of the Period From COVID-19 Symptom Onset to Confirmation on Disease Duration: Quantitative Analysis of Publicly Available Patient Data. J. Med. Internet Res. 2021;23:e29576. doi: 10.2196/29576.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29576</ArticleId><ArticleId IdType="pmc">PMC8412132</ArticleId><ArticleId IdType="pubmed">34280114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartard C., Chaqroun A., Settembre N., Gauchotte G., Lefevre B., Marchand E., Mazeaud C., Nguyen D.T., Martrille L., Koscinski I., et al. Multiorgan and Vascular Tropism of SARS-CoV-2. Viruses. 2022;14:515. doi: 10.3390/v14030515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030515</ArticleId><ArticleId IdType="pmc">PMC8955556</ArticleId><ArticleId IdType="pubmed">35336922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Le&#xf3;n S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. SSRN Electron. J. 2021;11:16144. doi: 10.2139/ssrn.3769978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3769978</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D., Simioni C., Neri L.M., Rizzo R., Semprini C.M., Occhionorelli S., Laface I., Sanz J.M., Schiuma G., Rizzo S., et al. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage. FASEB J. 2021;35:e21969. doi: 10.1096/fj.202100821RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100821RRR</ArticleId><ArticleId IdType="pubmed">34822202</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Levy J.H., Levi M., Connors J.M., Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit. Care Med. 2020;48:1358&#x2013;1364. doi: 10.1097/CCM.0000000000004458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004458</ArticleId><ArticleId IdType="pmc">PMC7255402</ArticleId><ArticleId IdType="pubmed">32467443</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 cytokine storm: The interplay between inflammation and coagulation. Lancet Respir. Med. 2020;8:e46&#x2013;e47. doi: 10.1016/S2213-2600(20)30216-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganier L., Morelli X., Borg J.P. CD147 (BSG) but not ACE2 expression is detectable in vascular endothelial cells within single cell RNA sequencing datasets derived from multiple tissues in healthy individuals. Med. Sci. 2020;36:42&#x2013;46. doi: 10.1051/medsci/2020197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1051/medsci/2020197</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel L., Chew K.Y., Stocks C.J., Yordanov T.E., Essebier P., Kulasinghe A., Monkman J., Dos Santos Miggiolaro A.F.R., Cooper C., de Noronha L., et al. Endothelial cells are not productively infected by SARS-CoV-2. Clin. Transl. Immunol. 2021;10:e1350. doi: 10.1002/cti2.1350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1350</ArticleId><ArticleId IdType="pmc">PMC8542944</ArticleId><ArticleId IdType="pubmed">34721846</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D., Gentili V., Rizzo S., Schiuma G., Beltrami S., Spadaro S., Strazzabosco G., Campo G., Carosella E.D., Papi A., et al. Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion. Viruses. 2021;13:1855. doi: 10.3390/v13091855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091855</ArticleId><ArticleId IdType="pmc">PMC8473385</ArticleId><ArticleId IdType="pubmed">34578436</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen B., Favaloro E.J., Lippi G., Van Cott E.M. Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19) Semin. Thromb. Hemost. 2020;46:845&#x2013;849. doi: 10.1055/s-0040-1715458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715458</ArticleId><ArticleId IdType="pmc">PMC7645834</ArticleId><ArticleId IdType="pubmed">32877961</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennings G.J., Yong A.S., Kritharides L. Expression of EMMPRIN (CD147) on circulating platelets in vivo. J. Thromb. Haemost. 2010;8:472&#x2013;481. doi: 10.1111/j.1538-7836.2009.03716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03716.x</ArticleId><ArticleId IdType="pubmed">19995409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutusaus A., Mari M., Ortiz-Perez J.T., Nicolaes G.A.F., Morales A., Garcia de Frutos P. Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis. Cells. 2020;9:2186. doi: 10.3390/cells9102186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102186</ArticleId><ArticleId IdType="pmc">PMC7601762</ArticleId><ArticleId IdType="pubmed">32998369</ArticleId></ArticleIdList></Reference><Reference><Citation>Castoldi E., Hackeng T.M. Regulation of coagulation by protein S. Curr. Opin. Hematol. 2008;15:529&#x2013;536. doi: 10.1097/MOH.0b013e328309ec97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e328309ec97</ArticleId><ArticleId IdType="pubmed">18695379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzicka J.A. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease. Thromb. Res. 2020;196:257&#x2013;259. doi: 10.1016/j.thromres.2020.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.09.007</ArticleId><ArticleId IdType="pmc">PMC7476440</ArticleId><ArticleId IdType="pubmed">32920296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wypasek E., Karpinski M., Alhenc-Gelas M., Undas A. Venous thromboembolism associated with protein S deficiency due to Arg451* mutation in PROS1 gene: A case report and a literature review. J. Genet. 2017;96:1047&#x2013;1051. doi: 10.1007/s12041-017-0865-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12041-017-0865-9</ArticleId><ArticleId IdType="pubmed">29321366</ArticleId></ArticleIdList></Reference><Reference><Citation>Baez-Santos Y.M., St John S.E., Mesecar A.D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21&#x2013;38. doi: 10.1016/j.antiviral.2014.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.12.015</ArticleId><ArticleId IdType="pmc">PMC5896749</ArticleId><ArticleId IdType="pubmed">25554382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli V.S., Plautz W., Majumder R. The Journey of Protein S from an Anticoagulant to a Signaling Molecule. JSM Biochem. Mol. Biol. 2016;3:1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5973875</ArticleId><ArticleId IdType="pubmed">29854880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziebuhr J. The coronavirus replicase. Curr. Top Microbiol. Immunol. 2005;287:57&#x2013;94. doi: 10.1007/3-540-26765-4_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/3-540-26765-4_3</ArticleId><ArticleId IdType="pmc">PMC7121973</ArticleId><ArticleId IdType="pubmed">15609509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., Limami Y., Zaid N., Sadki K., Ben El Haj R., et al. Platelets Can Associate with SARS-CoV-2 RNA and Are Hyperactivated in COVID-19. Circ. Res. 2020;127:1404&#x2013;1418. doi: 10.1161/CIRCRESAHA.120.317703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D., Gentili V., Rizzo S., Schiuma G., Beltrami S., Strazzabosco G., Fernandez M., Caccuri F., Caruso A., Rizzo R. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms. 2021;9:1820. doi: 10.3390/microorganisms9091820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091820</ArticleId><ArticleId IdType="pmc">PMC8465566</ArticleId><ArticleId IdType="pubmed">34576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroni M., Pavani G., Marescotti D., Kaabache T., Borgel D., Gandrille S., Marchetti G., Legnani C., D&#x2019;Angelo A., Pinotti M., et al. Membrane binding and anticoagulant properties of protein S natural variants. Thromb. Res. 2010;125:e33&#x2013;e39. doi: 10.1016/j.thromres.2009.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2009.09.015</ArticleId><ArticleId IdType="pubmed">19878975</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586&#x2013;590. doi: 10.1007/s00134-020-05985-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05985-9</ArticleId><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamboni P., Bortolotti D., Occhionorelli S., Traina L., Neri L.M., Rizzo R., Gafa R., Passaro A. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J. Intern. Med. 2022;291:224&#x2013;231. doi: 10.1111/joim.13385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13385</ArticleId><ArticleId IdType="pmc">PMC8662187</ArticleId><ArticleId IdType="pubmed">34437741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Narayan R.K., Kumari C., Faiq M.A., Kulandhasamy M., Kant K., Pareek V. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med. Hypotheses. 2020;145:110320. doi: 10.1016/j.mehy.2020.110320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110320</ArticleId><ArticleId IdType="pmc">PMC7525265</ArticleId><ArticleId IdType="pubmed">33032170</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel E.B. COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennings G.J., Kritharides L. CD147 in cardiovascular disease and thrombosis. Semin. Thromb. Hemost. 2014;40:747&#x2013;755. doi: 10.1055/s-0034-1390001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1390001</ArticleId><ArticleId IdType="pubmed">25280014</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C., Galbiati S., Vanetti C., Vago R., Clerici M., Tacchetti C., Daniele T. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells. 2021;10:1434. doi: 10.3390/cells10061434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061434</ArticleId><ArticleId IdType="pmc">PMC8226513</ArticleId><ArticleId IdType="pubmed">34201214</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri N., De Lorenzo R., Clementi N., Antonia Diotti R., Criscuolo E., Godino C., Tresoldi C., Angels For COVID-Bio B.S.G.B., Bonini C., Clementi M., et al. Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19. J. Thromb. Haemost. 2022;20:434&#x2013;448. doi: 10.1111/jth.15575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15575</ArticleId><ArticleId IdType="pmc">PMC8646617</ArticleId><ArticleId IdType="pubmed">34710269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemzadeh M., Ahmadi J., Hosseini E. Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis? Thromb. Res. 2022;213:179&#x2013;194. doi: 10.1016/j.thromres.2022.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.03.022</ArticleId><ArticleId IdType="pmc">PMC8969450</ArticleId><ArticleId IdType="pubmed">35397313</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds N.D., Aceves N.M., Liu J.L., Compton J.R., Leary D.H., Freitas B.T., Pegan S.D., Doctor K.Z., Wu F.Y., Hu X., et al. The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease. ACS Infect. Dis. 2021;7:1483&#x2013;1502. doi: 10.1021/acsinfecdis.0c00866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00866</ArticleId><ArticleId IdType="pmc">PMC8171221</ArticleId><ArticleId IdType="pubmed">34019767</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>